Most notably, we completed U.S. and Japanese filings for crizotinib in ALK-positive non-small cell lung cancer and U.S. and EU filings for axitinib in advanced renal cell carcinoma.

FORBES: Pfizer Suffers Loss Of Exclusivity, Braces Itself For Lipitor Expiration

Another carrier favored by Neidl is Alaska Air Group (nyse: ALK - news - people ), the holding company of Alaska Airlines, which serves cities along the west coast of Canada, the U.S. and Mexico.

FORBES: The Friendly Skies

Separately, Pfizer said that the Food and Drug Administration has approved Xalkori capsules, which the company calls the first-ever drug targeting anaplastic lymphoma kinase, or ALK, for the treatment of locally advanced or metastatic non-small cell lung cancer that is ALK-positive.

FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer